Total records found: 123
Hide HeadlineShow Headline
Sort
Release Time Stock Code Stock Short Name Document
Release Time: 26/10/2026 17:49 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT PRESENTATION OF UPDATED CLINICAL AND TRANSLATIONAL DATA OF LBL-024 FOR EXTRAPULMONARY NEUROENDOCRINE CARCINOMA, BILIARY TRACT CANCER AND COLORECTAL CANCER AT 2026 ESMO (490KB)
Release Time: 25/10/2026 18:06 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT ORAL PRESENTATION OF UPDATED CLINICAL DATA OF LBL-034 FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA AT 2026 ESMO (469KB)
Release Time: 20/10/2026 17:10 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT PHASE II STUDY OF LBL-024 (OPAMTISTOMIG, PD-L1/4-1BB BISPECIFIC ANTIBODY) AS FIRST-LINE TREATMENT FOR GASTRIC CANCER PROGRESSES TO EXPANSION STAGE (479KB)
Release Time: 19/10/2026 19:40 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT ABSTRACTS OF SIX STUDIES PUBLISHED AT 2026 ESMO (495KB)
Release Time: 16/10/2026 12:05 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT FIRST PATIENT ENROLLED IN PHASE IB/II CLINICAL TRIAL OF LBL-024 (OPAMTISTOMIG, PD-L1/4-1BB BISPECIFIC ANTIBODY) IN COMBINATION THERAPY FOR METASTATIC COLORECTAL CANCER (476KB)
Release Time: 12/10/2026 06:04 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT LBL-024 (OPAMTISTOMIG, PD-L1/4-1BB BISPECIFIC ANTIBODY) GRANTED FAST TRACK DESIGNATION BY THE U.S. FDA FOR FIRST-LINE TREATMENT OF ADVANCED BILIARY TRACT CANCER (494KB)
Release Time: 02/10/2026 16:49 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026 (69KB)
Release Time: 28/09/2026 12:13 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT LBL-024 (OPAMTISTOMIG, PD-L1/4-1BB BISPECIFIC ANTIBODY) GRANTED ORPHAN DRUG DESIGNATION IN JAPAN (472KB)
Release Time: 23/09/2026 21:47 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Financial Statements/ESG Information - [Interim/Half-Year Report]
2026 INTERIM REPORT (10MB)
Release Time: 21/09/2026 22:12 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT PIVOTAL REGISTRATIONAL PHASE IIB STUDY OF LBL-024 (OPAMTISTOMIG, PD-L1/4-1BB BISPECIFIC ANTIBODY) MONOTHERAPY IN ADVANCED EP-NEC SELECTED AS LBA AND THREE STUDIES SELECTED FOR PROFFERED PAPER PRESENTATIONS AT 2026 ESMO (482KB)
Release Time: 14/09/2026 17:10 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT UPDATED DATA FROM PHASE II CLINICAL STUDY OF LBL-024 (OPAMTISTOMIG, PD-L1/4-1BB BISPECIFIC ANTIBODY) IN COMBINATION WITH CHEMOTHERAPY AS FIRST-LINE TREATMENT FOR NSCLC PRESENTED ORALLY AT WCLC 2026 (486KB)
Release Time: 02/09/2026 16:47 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2026 (69KB)
Release Time: 31/08/2026 16:30 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Interim Results]
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026 (9MB)
Release Time: 25/08/2026 06:31 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT LBL-024 (OPAMTISTOMIG, PD-L1/4-1BB BISPECIFIC ANTIBODY) PHASE II CLINICAL STUDY FOR FIRST-LINE TREATMENT OF ESCC ADVANCES TO EXPANSION STAGE (476KB)
Release Time: 21/08/2026 16:41 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT LBL-024 (OPAMTISTOMIG, PD-L1/4-1BB BISPECIFIC ANTIBODY) NEW DRUG APPLICATION ACCEPTED FOR REVIEW BY NMPA (476KB)
Release Time: 20/08/2026 08:05 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT LBL-024 (OPAMTISTOMIG, PD-L1/4-1BB BISPECIFIC ANTIBODY) PHASE II CLINICAL STUDY ABSTRACT FOR FIRST-LINE TREATMENT OF NSCLC PUBLISHED ON WCLC WEBSITE (475KB)
Release Time: 20/08/2026 06:15 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT OBLENIO EXERCISED OPTION TO RETAIN ITS LICENSE FOR LBL-051 (463KB)
Release Time: 19/08/2026 18:10 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Date of Board Meeting]
DATE OF BOARD MEETING (451KB)
Release Time: 06/08/2026 06:02 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT PHASE II STUDY OF LBL-024 (OPAMTISTOMIG, PD-L1/4-1BB BISPECIFIC ANTIBODY) FOR HEPATOCELLULAR CARCINOMA SUCCESSFULLY ENTERS EXPANSION PHASE (471KB)
Release Time: 04/08/2026 19:02 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Share Scheme / Other - Business Update]
VOLUNTARY ANNOUNCEMENT PARTNER OBLENIO DOSES FIRST PATIENTS IN PHASE IA TRIAL OF LBL-051 FOR REFRACTORY AUTOIMMUNE DISEASES AND SUPPLEMENTAL ANNOUNCEMENT (471KB)
Release Time: 03/08/2026 16:34 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2026 (69KB)
Release Time: 03/08/2026 06:05 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT LBL-024 (OPAMTISTOMIG, PD-L1/4-1BB BISPECIFIC ANTIBODY) RECEIVED IND APPROVAL FROM NMPA FOR THE TREATMENT OF METASTATIC COLORECTAL CANCER (472KB)
Release Time: 30/07/2026 17:45 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - COMPLETION OF FULL PATIENT ENROLLMENT IN PHASE II STUDY OF LBL-024 (OPAMTISTOMIG, PD-L1/4-1BB BISPECIFIC ANTIBODY) FOR BILIARY TRACT CANCER (476KB)
Release Time: 24/07/2026 18:00 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Miscellaneous]
VOLUNTARY ANNOUNCEMENT VOLUNTARY EXTENSION OF LOCK-UP PERIOD GIVEN BY THE CHIEF EXECUTIVE OFFICER (57KB)
Release Time: 13/07/2026 16:35 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT MULTIPLE RESEARCH RESULTS SELECTED FOR PRESENTATION AT 2026 ESMO (62KB)
Release Time: 10/07/2026 12:27 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - LBL-024 (OPAMTISTOMIG, PD-L1/4-1BB BISPECIFIC ANTIBODY) INCLUDED IN THE PRIORITY REVIEW AND APPROVAL PROCEDURE FOR THE TREATMENT OF ADVANCED EXTRAPULMONARY NEUROENDOCRINE CARCINOMA (EP-NEC) (64KB)
Release Time: 02/07/2026 17:00 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2026 (71KB)
Release Time: 01/07/2026 19:45 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Share Scheme]
GRANT OF AWARDS PURSUANT TO THE H SHARE AWARD SCHEME (64KB)
Release Time: 25/06/2026 18:00 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT PARTNER OBLENIO CLOSES OVERSUBSCRIBED US$62 MILLION SERIES B FINANCING ROUND TO ACCELERATE CLINICAL DEVELOPMENT OF LBL-051 (59KB)
Release Time: 05/06/2026 19:23 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Next Day Disclosure Returns - [Others]
Next Day Disclosure Return (86KB)
Release Time: 05/06/2026 19:23 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Inside Information]
INSIDE INFORMATION COMPLETION OF THE H SHARE FULL CIRCULATION (47KB)
Release Time: 01/06/2026 17:32 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2026 (68KB)
Release Time: 28/05/2026 12:00 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - ORAL PRESENTATION OF PHASE II CLINICAL STUDY RESULTS OF LBL-024 (OPAMTISTOMIG, PD-L1/4-1BB BISPECIFIC ANTIBODY) AT 2026 WCLC (61KB)
Release Time: 20/05/2026 19:12 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Miscellaneous]
VOLUNTARY ANNOUNCEMENT PROPOSED ON-MARKET ACQUISITION OF H SHARES BY THE TRUSTEE IN THE AMOUNT OF UP TO US$50 MILLION UNDER THE H SHARE AWARD SCHEME (58KB)
Release Time: 19/05/2026 07:12 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - PHASE III CLINICAL STUDY OF LBL-024 (OPAMTISTOMIG, PD-L1/4-1BB BISPECIFIC ANTIBODY) FOR ADVANCED EXTRAPULMONARY NEUROENDOCRINE CARCINOMA (EP-NEC) APPROVED BY CDE (66KB)
Release Time: 15/05/2026 17:16 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Constitutional Documents
ARTICLES OF ASSOCIATION (182KB)
Release Time: 15/05/2026 17:15 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [List of Directors and their Role and Function]
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS (66KB)
Release Time: 15/05/2026 17:15 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Results of AGM / Change in Directors or of Important Executive Functions or Responsibilities...
More
Announcements and Notices - [Results of AGM / Change in Directors or of Important Executive Functions or Responsibilities / Amendment of Constitutional Documents]
]
POLL RESULTS OF THE ANNUAL GENERAL MEETING APPOINTMENT OF NON-EXECUTIVE DIRECTOR AND AMENDMENTS TO THE ARTICLES OF ASSOCIATION (68KB)
Release Time: 14/05/2026 21:08 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Inside Information]
INSIDE INFORMATION LISTING APPROVAL GRANTED BY THE STOCK EXCHANGE FOR THE IMPLEMENTATION OF H SHARE FULL CIRCULATION BY THE COMPANY (93KB)
Release Time: 08/05/2026 20:12 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Inside Information]
INSIDE INFORMATION ISSUANCE OF FILING NOTICE BY THE CSRC FOR THE H SHARE FULL CIRCULATION AND PROPOSED IMPLEMENTATION OF H SHARE FULL CIRCULATION BY THE COMPANY (51KB)
Release Time: 06/05/2026 16:31 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026 (68KB)
Release Time: 06/05/2026 08:29 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - LBL-047 PRIORITIZED FOR CLINICAL DEVELOPMENT IN SJOGREN'S DISEASE, SYSTEMIC LUPUS ERYTHEMATOSUS, AND DERMATOMYOSITIS (59KB)
Release Time: 24/04/2026 21:46 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Proxy Forms
PROXY FORM FOR THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, MAY 15, 2026 (91KB)
Release Time: 24/04/2026 21:45 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Notice of AGM / Closure of Books or Change of Book Closure Period]
NOTICE OF ANNUAL GENERAL MEETING (80KB)
Release Time: 24/04/2026 21:45 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Circulars - [General Mandate / Explanatory Statement for Repurchase of Shares / Re-election or Appointment of Director...
More
Circulars - [General Mandate / Explanatory Statement for Repurchase of Shares / Re-election or Appointment of Director subject to Shareholders' Approval / Amendment of Constitutional Documents / Other]
]
(1) 2025 WORK REPORT OF THE BOARD OF DIRECTORS; (2) 2025 FINAL FINANCIAL REPORT; (3) 2025 ANNUAL REPORT; (4) 2025 PROFIT DISTRIBUTION PLAN; (5) PROPOSED APPOINTMENT OF NON-EXECUTIVE DIRECTOR; (6) RE-APPOINTMENT OF AUDITOR; (7) 2026 DIRECTORS REMUNERATION PLAN; (8) GENERAL MANDATE TO ISSUE NEW SHARES; (9) GENERAL MANDATE TO REPURCHASE H SHARES; (10) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION; AND NOTICE OF THE ANNUAL GENERAL MEETING (135KB)
Release Time: 24/04/2026 21:44 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Financial Statements/ESG Information - [Environmental, Social and Governance Information/Report]
2025 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT (12MB)
Release Time: 24/04/2026 21:44 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Financial Statements/ESG Information - [Annual Report]
2025 ANNUAL REPORT (12MB)
Release Time: 24/04/2026 18:10 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Amendment of Constitutional Documents]
PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION (59KB)
Release Time: 21/04/2026 16:45 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - FIRST PATIENT ENROLLED IN PHASE II TRIAL OF LBL-024 (OPAMTISTOMIG, PD-L1/4-1BB BISPECIFIC ANTIBODY) FOR FIRST-LINE GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA (65KB)
Release Time: 08/04/2026 16:32 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - PHASE II STUDY OF LBL-024 (OPAMTISTOMIG, PD-L1/4-1BB BISPECIFIC ANTIBODY) FOR BILIARY TRACT CANCER SUCCESSFULLY ENTERS EXPANSION PHASE (65KB)
Release Time: 01/04/2026 11:01 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026 (68KB)
Release Time: 31/03/2026 16:54 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - RESEARCH ABSTRACTS ACCEPTED FOR PRESENTATION AT THE 2026 AACR ANNUAL MEETING (64KB)
Release Time: 27/03/2026 18:54 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [List of Directors and their Role and Function]
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS (66KB)
Release Time: 27/03/2026 18:53 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Change in Directors or of Important Executive Functions or Responsibilities]
(1) RESIGNATION OF NON-EXECUTIVE DIRECTOR; (2) PROPOSED APPOINTMENT OF NON-EXECUTIVE DIRECTOR AND (3) CHANGE IN COMPOSITION OF THE NOMINATION COMMITTEE (79KB)
Release Time: 27/03/2026 17:00 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Final Results / Closure of Books or Change of Book Closure Period]
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025 (2MB)
Release Time: 17/03/2026 16:30 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Date of Board Meeting]
DATE OF BOARD MEETING (52KB)
Release Time: 06/03/2026 17:11 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Miscellaneous]
VOLUNTARY ANNOUNCEMENT - INCLUSION AS A CONSTITUENT OF HANG SENG COMPOSITE INDEX AND INCLUSION IN THE STOCK LIST OF STOCK CONNECT SOUTHBOUND TRADING LINK (53KB)
Release Time: 06/03/2026 16:30 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - FIRST PATIENT ENROLLED IN PHASE II TRIAL OF LBL-024 (OPAMTISTOMIG, PD-L1/4-1BB BISPECIFIC ANTIBODY) FOR FIRST-LINE ESOPHAGEAL SQUAMOUS CELL CARCINOMA (65KB)
Release Time: 03/03/2026 12:23 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2026 (68KB)
Release Time: 10/02/2026 16:30 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - LBL-024 (OPAMTISTOMIG, PD-L1/4-1BB BISPECIFIC ANTIBODY) DOSED FIRST PATIENT IN PHASE IB/II TRIAL FOR RECURRENT OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER (65KB)
Release Time: 03/02/2026 12:25 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026 (68KB)
Release Time: 28/01/2026 08:22 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - LBL-034 (GPRC5D/CD3 BISPECIFIC T-CELL ENGAGER, TCE) GRANTED FAST TRACK DESIGNATION BY THE U.S. FDA (64KB)
Release Time: 22/01/2026 20:58 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT ORPHAN DRUG DESIGNATION (ODD) OF LBL-024 (OPAMTISTOMIG, PD-L1/4-1BB BISPECIFIC ANTIBODY) BY THE EUROPEAN COMMISSION FOR THE TREATMENT OF EXTRAPULMONARY NEUROENDOCRINE CARCINOMA (EP-NEC) (60KB)
Release Time: 14/01/2026 22:44 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT- LBL-024 (OPAMTISTOMIG, PD-L1/4-1BB BISPECIFIC ANTIBODY) GRANTED FAST TRACK DESIGNATION BY THE U.S. FDA (59KB)
Release Time: 05/01/2026 12:39 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025 (65KB)
Release Time: 31/12/2025 14:31 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Terms of Reference of the Nomination Committee]
TERMS OF REFERENCE OF THE NOMINATION COMMITTEE OF THE BOARD OF DIRECTORS (50KB)
Release Time: 31/12/2025 14:30 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Terms of Reference of the Remuneration Committee]
TERMS OF REFERENCE OF THE REMUNERATION COMMITTEE OF THE BOARD OF DIRECTORS (50KB)
Release Time: 31/12/2025 14:30 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Terms of Reference of the Audit Committee]
TERMS OF REFERENCE OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS (434KB)
Release Time: 23/12/2025 16:30 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - LBL-024 DOSED FIRST PATIENT IN PHASE IB/II TRIAL FOR PLATINUM-RESISTANT OVARIAN CANCER (68KB)
Release Time: 23/12/2025 12:23 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - LBL-047 DOSED FIRST SUBJECT IN PHASE I TRIAL (67KB)
Release Time: 17/12/2025 21:57 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Constitutional Documents
ARTICLES OF ASSOCIATION (182KB)
Release Time: 17/12/2025 18:50 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Results of EGM/SGM]
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON DECEMBER 17, 2025 (54KB)
Release Time: 15/12/2025 20:38 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Inside Information]
INSIDE INFORMATION - PROPOSED IMPLEMENTATION OF H SHARE FULL CIRCULATION PROGRAM BY THE COMPANY (64KB)
Release Time: 07/12/2025 18:13 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - LBL-034 CLINICAL DATA PRESENTED AT THE 67TH ASH ANNUAL MEETING (61KB)
Release Time: 03/12/2025 06:07 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025 (65KB)
Release Time: 01/12/2025 16:30 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - LBL-047 RECEIVED IND APPROVAL FROM NMPA (51KB)
Release Time: 28/11/2025 22:22 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Documents on Display
The H Share Award Scheme (309KB)
Release Time: 28/11/2025 22:18 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Proxy Forms
PROXY FORM FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON WEDNESDAY, DECEMBER 17, 2025 (77KB)
Release Time: 28/11/2025 22:14 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Notice of EGM/SGM]
NOTICE OF EXTRAORDINARY GENERAL MEETING (76KB)
Release Time: 28/11/2025 22:10 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Circulars - [Share Scheme / Amendment of Constitutional Documents]
(1) PROPOSED ADOPTION OF THE H SHARE AWARD SCHEME; (2) PROPOSED AUTHORIZATION TO THE BOARD OF DIRECTORS AND/OR THE DELEGATEE TO HANDLE MATTERS RELATING TO THE H SHARE AWARD SCHEME; (3) PROPOSED CANCELLATION OF THE SUPERVISORY COMMITTEE AND PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION; AND (4) NOTICE OF THE EXTRAORDINARY GENERAL MEETING (478KB)
Release Time: 27/11/2025 18:22 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Closure of Books or Change of Book Closure Period]
ANNOUNCEMENT BOOK CLOSURE PERIOD FOR EXTRAORDINARY GENERAL MEETING (55KB)
Release Time: 25/11/2025 22:45 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Share Scheme / Amendment of Constitutional Documents]
(1) PROPOSED ADOPTION OF THE H SHARE AWARD SCHEME; AND (2) PROPOSED CANCELLATION OF THE SUPERVISORY COMMITTEE AND PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION (82KB)
Release Time: 10/11/2025 16:39 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - LBL-024 DOSED FIRST PATIENT IN PHASE II TRIAL OF FIRST-LINE TREATMENT FOR HEPATOCELLULAR CARCINOMA (63KB)
Release Time: 07/11/2025 12:00 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Miscellaneous]
VOLUNTARY ANNOUNCEMENT - INCLUSION IN THE MSCI GLOBAL SMALL CAP INDEXES (53KB)
Release Time: 04/11/2025 16:35 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025 (65KB)
Release Time: 04/11/2025 06:06 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - FURTHER ANNOUNCEMENT ON RESEARCH ABSTRACTS ACCEPTED FOR PRESENTATION AT THE 67TH ASH ANNUAL MEETING (64KB)
Release Time: 27/10/2025 18:05 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - LBL-024 DOSED FIRST PATIENT IN PHASE II TRIAL OF FIRST-LINE TREATMENT FOR BILIARY TRACT CANCER (51KB)
Release Time: 17/10/2025 17:16 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Inside Information]
CLARIFICATION ANNOUNCEMENT (54KB)
Release Time: 16/10/2025 22:36 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Inside Information]
(REVISED) INSIDE INFORMATION - EXCLUSIVE GLOBAL LICENSE AGREEMENT WITH DIANTHUS FOR LBL-047 (82KB)
Release Time: 16/10/2025 20:48 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Inside Information]
INSIDE INFORMATION - EXCLUSIVE GLOBAL LICENSE AGREEMENT WITH DIANTHUS FOR LBL-047 (77KB)
Release Time: 09/10/2025 06:22 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT RESEARCH RESULTS OF TWO INNOVATIVE DRUGS TO BE PRESENTED AT THE 67TH ASH ANNUAL MEETING (53KB)
Release Time: 02/10/2025 16:32 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025 (65KB)
Release Time: 26/09/2025 21:49 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Financial Statements/ESG Information - [Interim/Half-Year Report]
2025 INTERIM REPORT (3MB)
Release Time: 22/09/2025 12:00 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT-LBL-047 RECEIVED IND APPROVAL FROM THE U.S. FDA (74KB)
Release Time: 17/09/2025 22:37 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Constitutional Documents
ARTICLES OF ASSOCIATION (191KB)
Release Time: 17/09/2025 22:36 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Amendment of Constitutional Documents]
AMENDMENTS TO THE ARTICLES OF ASSOCIATION (59KB)
Release Time: 12/09/2025 12:18 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - LBL-024 DOSED FIRST PATIENT IN MELANOMA PHASE IB/II TRIAL OF OPAMTISTOMIG (62KB)
Release Time: 08/09/2025 20:47 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Circulars - [Other]
Notification Letter and Reply Form to Non-registered Shareholders - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications (780KB)
Release Time: 08/09/2025 20:47 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Circulars - [Other]
Notification Letter and Reply Form to Registered Shareholders - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications (853KB)
Release Time: 02/09/2025 17:41 Stock Code: 09887 Stock Short Name: LEADS BIOLABS-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025 (66KB)
Showing 100 of 123 records
Showing 100 of 123 records
Disclaimer

Information contained in the materials available under the web page containing the hyperlink to this disclaimer is posted on this website for the purpose of providing information to the public in Hong Kong. It is not intended as investment advice and must not be relied on as such. It is the sole responsibility of any person who is located outside of Hong Kong to check and comply with all applicable laws and regulations before accessing and using the materials and information.

Please note that the web page contains materials and information provided to HKEX electronically (including information provided in electronic format) by listed issuers, new listing applicants and relevant parties and there is no agency, employee or partner relationship between HKEX and such parties. HKEX does not assume responsibility for screening, editing or monitoring such materials and the information contained in the materials. The information contained in the materials is not verified by HKEX.

HKEX and/or its subsidiaries take no responsibility for the materials and information available under the web page, make no representation as to their accuracy, reliability, completeness or ownership and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the information. Some materials may contain hyperlinks to external websites or web pages for which HKEX and/or its subsidiaries are not responsible. (Please see HKEX's "Hyperlink Policy").

Nothing herein shall constitute or be considered to be a limitation upon or a waiver of the privileges and immunities of HKEX and its subsidiaries, which are specifically reserved.

Copyright exists in the information and materials available under the web page and may belong to HKEX, to the author or to any other party depending on the circumstances of publications. Reproduction, distribution, use and/or linking without consent from the relevant parties is not permitted.

If you believe or are aware that any information contained in the materials is inaccurate, erroneous, unlawful, obscene, defamatory or infringes any intellectual property rights of a third party, please contact HKEX e-Submission by email at: ESSHotline@hkex.com.hk.